Open AccessRituximab for refractory granulomatous eye disease
Author(s) -
Robert P. Baughman,
Lower,
Kaufman
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s35521
Subject(s) - medicine , rituximab , refractory (planetary science) , disease , ophthalmology , dermatology , immunology , pathology , antibody , physics , astrobiology
To determine the effectiveness of rituximab therapy for patients with granulomatous disease of the eye.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom